• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构药物发现的综合计算方法和工具。

Integrated Computational Approaches and Tools forAllosteric Drug Discovery.

机构信息

Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University,Grahamstown 6140, South Africa.

Graduate Program in Computational and Data Sciences, Keck Center for Science and Engineering, SchmidCollege of Science and Technology, Chapman University, One University Drive, Orange, California 92866,USA.

出版信息

Int J Mol Sci. 2020 Jan 28;21(3):847. doi: 10.3390/ijms21030847.

DOI:10.3390/ijms21030847
PMID:32013012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036869/
Abstract

Understanding molecular mechanisms underlying the complexity of allosteric regulationin proteins has attracted considerable attention in drug discovery due to the benefits and versatilityof allosteric modulators in providing desirable selectivity against protein targets while minimizingtoxicity and other side effects. The proliferation of novel computational approaches for predictingligand-protein interactions and binding using dynamic and network-centric perspectives has ledto new insights into allosteric mechanisms and facilitated computer-based discovery of allostericdrugs. Although no absolute method of experimental and allosteric drug/site discoveryexists, current methods are still being improved. As such, the critical analysis and integration ofestablished approaches into robust, reproducible, and customizable computational pipelines withexperimental feedback could make allosteric drug discovery more efficient and reliable. In this article,we review computational approaches for allosteric drug discovery and discuss how these tools can beutilized to develop consensus workflows for identification of allosteric sites and modulatorswith some applications to pathogen resistance and precision medicine. The emerging realization thatallosteric modulators can exploit distinct regulatory mechanisms and can provide access to targetedmodulation of protein activities could open opportunities for probing biological processes and design of drug combinations with improved therapeutic indices and a broad range of activities.

摘要

理解蛋白质变构调节复杂性的分子机制在药物发现中引起了相当大的关注,因为变构调节剂具有提供针对蛋白质靶标的理想选择性、最小化毒性和其他副作用的益处和多功能性。使用动态和以网络为中心的观点预测配体-蛋白质相互作用和结合的新型计算方法的激增,导致对变构机制有了新的认识,并促进了基于计算机的变构药物发现。虽然不存在用于实验和变构药物/位点发现的绝对方法,但目前的方法仍在不断改进。因此,将成熟的方法进行批判性分析和整合到具有实验反馈的稳健、可重复和可定制的计算管道中,可以使变构药物发现更高效、更可靠。在本文中,我们回顾了变构药物发现的计算方法,并讨论了如何利用这些工具来开发用于鉴定变构位点和调节剂的共识工作流程,以及一些在病原体耐药性和精准医学中的应用。人们逐渐认识到,变构调节剂可以利用独特的调节机制,并可以提供针对蛋白质活性的靶向调节,这为探索生物过程和设计具有改善的治疗指数和广泛活性的药物组合开辟了机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/8159fa916b85/ijms-21-00847-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/104fd62c6672/ijms-21-00847-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/1c10886d6dde/ijms-21-00847-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/8159fa916b85/ijms-21-00847-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/104fd62c6672/ijms-21-00847-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/1c10886d6dde/ijms-21-00847-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/7036869/8159fa916b85/ijms-21-00847-g003.jpg

相似文献

1
Integrated Computational Approaches and Tools forAllosteric Drug Discovery.变构药物发现的综合计算方法和工具。
Int J Mol Sci. 2020 Jan 28;21(3):847. doi: 10.3390/ijms21030847.
2
Discovery of hidden allosteric sites as novel targets for allosteric drug design.发现隐藏的变构位点作为变构药物设计的新靶点。
Drug Discov Today. 2018 Feb;23(2):359-365. doi: 10.1016/j.drudis.2017.10.001. Epub 2017 Oct 10.
3
Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.变构药物发现的计算工具:位点识别与聚焦文库设计
Methods Mol Biol. 2017;1529:439-446. doi: 10.1007/978-1-4939-6637-0_23.
4
Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.G蛋白偶联受体变构调节剂和双位点配体开发中的计算进展
AAPS J. 2015 Sep;17(5):1080-95. doi: 10.1208/s12248-015-9776-y. Epub 2015 May 5.
5
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.分子动力学模拟技术在药物发现和药理学中的应用:关注变构药物。
Methods Mol Biol. 2021;2253:245-254. doi: 10.1007/978-1-0716-1154-8_14.
6
Current and Future Challenges in GPCR Drug Discovery.G蛋白偶联受体药物研发中的当前与未来挑战
Methods Mol Biol. 2018;1705:1-21. doi: 10.1007/978-1-4939-7465-8_1.
7
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.变构调节剂的发现:从偶然发现到基于结构的设计。
J Med Chem. 2019 Jul 25;62(14):6405-6421. doi: 10.1021/acs.jmedchem.8b01749. Epub 2019 Mar 7.
8
Harnessing allostery: a novel approach to drug discovery.利用变构效应:一种新的药物发现方法。
Med Res Rev. 2014 Nov;34(6):1242-85. doi: 10.1002/med.21317. Epub 2014 May 14.
9
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.用于变构药物合理发现的新兴计算方法
Chem Rev. 2016 Jun 8;116(11):6370-90. doi: 10.1021/acs.chemrev.5b00631. Epub 2016 Apr 13.
10
HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.药物设计中多个结合位点通讯与别构调节的高性能计算分析:以热休克蛋白为例的案例研究
Curr Drug Targets. 2016;17(14):1610-1625. doi: 10.2174/1389450117666151209123646.

引用本文的文献

1
How residence time works in allosteric drugs.变构药物中的驻留时间是如何起作用的。
Curr Opin Struct Biol. 2025 Aug 29;94:103149. doi: 10.1016/j.sbi.2025.103149.
2
Exploiting allosteric modulation: a new frontier for precision medicine.利用变构调节:精准医学的新前沿。
Mol Biol Rep. 2025 Jun 4;52(1):549. doi: 10.1007/s11033-025-10650-9.
3
Real Way to Target Gram-Negative Pathogens: Discovery of a Novel Antibiotic Class.靶向革兰氏阴性病原体的真正方法:新型抗生素类别的发现

本文引用的文献

1
Alarming surge in drug-resistant HIV uncovered.发现耐药性艾滋病毒激增,令人担忧。
Nature. 2019 Jul 30. doi: 10.1038/d41586-019-02316-x.
2
The Semiempirical Quantum Mechanical Scoring Function for In Silico Drug Design.用于计算机辅助药物设计的半经验量子力学评分函数。
Chempluschem. 2013 Sep;78(9):921-931. doi: 10.1002/cplu.201300199. Epub 2013 Aug 13.
3
Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Associated With Pyrazinamide Resistance.与吡嗪酰胺耐药相关的PncA的Asp12Ala、Pro54Leu和His57Pro临床突变体背后的结构动力学
J Med Chem. 2025 May 22;68(10):10128-10138. doi: 10.1021/acs.jmedchem.5c00112. Epub 2025 Mar 31.
4
Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge.疾病中的变构作用:抗癌药物、靶点口袋与肿瘤异质性挑战
J Mol Biol. 2025 Feb 26:169050. doi: 10.1016/j.jmb.2025.169050.
5
Toward the Prediction of Binding Events in Very Flexible, Allosteric, Multidomain Proteins.迈向对非常灵活的、变构的、多结构域蛋白质中结合事件的预测。
J Chem Inf Model. 2025 Feb 24;65(4):2052-2065. doi: 10.1021/acs.jcim.4c01810. Epub 2025 Feb 5.
6
Mechanisms of Cbl-Mediated Ubiquitination of Proteins in T and Natural Killer Cells and Effects on Immune Cell Functions.Cbl介导的T细胞和自然杀伤细胞中蛋白质泛素化的机制及其对免疫细胞功能的影响。
Life (Basel). 2024 Dec 3;14(12):1592. doi: 10.3390/life14121592.
7
Exploring Binding Sites in Chagas Disease Protein TcP21 Using Integrated Mixed Solvent Molecular Dynamics Approaches.使用综合混合溶剂分子动力学方法探索恰加斯病蛋白TcP21中的结合位点。
J Chem Inf Model. 2025 Jan 13;65(1):363-377. doi: 10.1021/acs.jcim.4c01927. Epub 2024 Dec 17.
8
Virtual screening and molecular dynamics studies of novel small molecules targeting DHODH: identification of potential inhibitors.针对二氢乳清酸脱氢酶(DHODH)的新型小分子的虚拟筛选和分子动力学研究:潜在抑制剂的鉴定
In Silico Pharmacol. 2024 Nov 27;12(2):113. doi: 10.1007/s40203-024-00281-6. eCollection 2024.
9
MEF-AlloSite: an accurate and robust Multimodel Ensemble Feature selection for the Allosteric Site identification model.MEF-AlloSite:一种用于变构位点识别模型的准确且稳健的多模型集成特征选择方法。
J Cheminform. 2024 Oct 23;16(1):116. doi: 10.1186/s13321-024-00882-5.
10
Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence.通过人工智能为创新治疗应用彻底改变分子设计。
Molecules. 2024 Sep 29;29(19):4626. doi: 10.3390/molecules29194626.
Front Bioeng Biotechnol. 2019 Dec 10;7:404. doi: 10.3389/fbioe.2019.00404. eCollection 2019.
4
Establishing Computational Approaches Towards Identifying Malarial Allosteric Modulators: A Case Study of Hsp70s.建立识别疟原虫变构调节剂的计算方法:以 Hsp70s 为例。
Int J Mol Sci. 2019 Nov 8;20(22):5574. doi: 10.3390/ijms20225574.
5
Mechanism of Action of Non-Synonymous Single Nucleotide Variations Associated with -Carbonic Anhydrase II Deficiency.与 - 碳酸酐酶 II 缺乏相关的非同义单核苷酸变异的作用机制。
Molecules. 2019 Nov 4;24(21):3987. doi: 10.3390/molecules24213987.
6
Defining subpopulations of differential drug response to reveal novel target populations.定义具有不同药物反应的亚群,以揭示新的靶人群。
NPJ Syst Biol Appl. 2019 Oct 3;5:36. doi: 10.1038/s41540-019-0113-4. eCollection 2019.
7
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.脱靶毒性是临床试验中癌症药物的常见作用机制。
Sci Transl Med. 2019 Sep 11;11(509). doi: 10.1126/scitranslmed.aaw8412.
8
Data-driven computational analysis of allosteric proteins by exploring protein dynamics, residue coevolution and residue interaction networks.通过探索蛋白质动力学、残基协同进化和残基相互作用网络,对变构蛋白进行数据驱动的计算分析。
Biochim Biophys Acta Gen Subj. 2019 Jul 19. doi: 10.1016/j.bbagen.2019.07.008.
9
On the Allosteric Effect of nsSNPs and the Emerging Importance of Allosteric Polymorphism.非编码区单核苷酸多态性的变构效应及变构多态性的重要性日益凸显
J Mol Biol. 2019 Sep 6;431(19):3933-3942. doi: 10.1016/j.jmb.2019.07.012. Epub 2019 Jul 12.
10
Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.2006年至2017年美国一家参考实验室的HIV-1耐药性突变趋势
AIDS Res Hum Retroviruses. 2019 Aug;35(8):698-709. doi: 10.1089/AID.2019.0063. Epub 2019 Jul 10.